
Loading, please wait...

Loading, please wait...

Effective Epilepsy Medication Monitoring is essential for patient safety. Therefore, the All India Institute of Medical Sciences (AIIMS) in New Delhi has introduced a specialized facility for monitoring anti-epilepsy drug levels. Specifically, the service tracks levetiracetam and lamotrigine in the blood. Doctors explain that the same dose affects patients differently due to unique metabolic rates. Consequently, inaccurate drug levels can lead to seizure recurrence or medication toxicity.
Personalizing treatment through monitoring offers several advantages for clinicians and patients alike. First, it ensures that drug concentrations remain within the therapeutic window. Second, it helps identify toxicity risks before they cause severe side effects. Furthermore, the test detects cases where medicines fail to reach effective levels despite regular intake. Because private laboratories charge between Rs 6,000 and Rs 10,000 per drug, this low-cost initiative significantly improves access to precision-based care.
The new facility is located at the AIIMS Neurosciences Centre and extends services to the NCI-AIIMS Jhajjar campus. Currently, patients can access these tests free of cost, though subsidized rates may apply later. Additionally, results are available online through the e-Hospital and ORS portals. This digital integration ensures that both outpatient and admitted patients receive timely data. Moreover, advanced neurodiagnostic facilities like these help manage complex neurological disorders more effectively.
Q1: Which specific medications does the new AIIMS TDM facility monitor?
The facility currently monitors levels of two common anti-epilepsy drugs, levetiracetam and lamotrigine, to ensure they are at safe and effective levels.
Q2: How much do these TDM tests cost at AIIMS?
The tests are currently provided free of charge at AIIMS. However, the institute may introduce highly subsidized rates in the future as per their policy.
Q3: Is the monitoring service available for both outpatients and admitted patients?
Yes, the facility serves both outpatients (OPD) and admitted patients at AIIMS New Delhi and the NCI-AIIMS Jhajjar campus.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


AIIMS New Delhi has introduced a low-cost Therapeutic Drug Monitoring service for epilepsy drugs to personalize dosages and minimize medication side effects...
2 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today